CBD/Hemp Crime Health & Medicine Law News U.S.

The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD And Other Cannabinoids

Photo by Eric Kayne/Stringer/Getty Images

The DEA’s rule could have a major chilling effect on the Hemp CBD industry or the fast-growing delta-8 THC market.

On August 20, 2020, the Drug Enforcement Administration (DEA) issued an interim rule on hemp, hemp-derived CBD (Hemp CBD) and other hemp-derived cannabinoids.

According to the DEA, “[t]he interim final rule merely conforms DEA’s regulations to the statutory amendments to the [Controlled Substances Act (CSA)] that have already taken effect, and it does not add additional requirements to the regulations.”

If you’re in the hemp derivative business, trust the DEA at your own peril. While it is true that the 2018 Farm Bill did legalize hemp, hemp derivatives, hemp extracts, and cannabinoids in hemp, it did not explicitly cover hemp processing. I recently wrote about this regulatory gap and you can see it on an infographic here.

The regulatory gap that skips over hemp processing is relevant to understand the danger of the DEA’s interim rule and how it is inconsistent with the 2018 Farm Bill.

To Read The Rest Of This Article By Daniel Shortt on The Fresh Toast
Published: August 24, 2020
SHARE
RELATED POSTS
Weedmaps, vape shop sued over fatal pot delivery shooting
California Assembly OKs medical cannabis on K-12 campuses
How Business Owners of Color are Affected by the Cannabis Industry

Leave Your Reply

*